Clinical Trial: Ticagrelor Versus Clopidogrel in Ischemic Stroke
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Ischemic Stroke
Study Type: INTERVENTIONAL
Official Title: Ticagrelor Versus Clopidogrel in Ischemic Stroke. a Randomized Double-blinded Controlled Trial
Brief Summary:
Along with the current clinical trial, the efficacy and safety of 180 mg loading dose of ticagrelor administered within the first 24 hours of first-ever ischemic stroke compared to 300 mg clopidogrel were assessed through NIHSS, mRS, duration of hospital stay, and possible adverse effects.
Read more